Cleared Traditional

K103165 - BLOOD SAMPLING SET

K103165 is an FDA 510(k) clearance for BLOOD SAMPLING SET, manufactured by Acacia, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K103165 · Acacia, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2010
Decision
14d
Days
Class 2
Risk

K103165 is an FDA 510(k) clearance for the BLOOD SAMPLING SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Acacia, Inc. (Brea, US). The FDA issued a Cleared decision on November 10, 2010 after a review of 14 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Acacia, Inc. devices

FDA 510(k) Submission Details - K103165

510(k) Number K103165 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2010
Decision Date November 10, 2010
Days to Decision 14 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 129d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 726
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K103165.
HOSPIRA PLUM INFUSION SET
K103224 · Hospira, Inc. · Jan 2011
HIGH PRESSURE SETS-400 PSI
K100576 · Icu Medical, Inc. · Dec 2010
INFUSION SETS
K103344 · Hospira, Inc. · Dec 2010
AMSINO I.V. ADMINISTRATION AND EXTENSION SETS
K101958 · Amsino International, Inc. · Sep 2010
ACCU-CHEK ULTRFLEX INFUSION SET
K101196 · Roche Diagnostics Corp. · Aug 2010
HOSPIRA INFUSION BLOOD SETS
K101677 · Hospira, Inc. · Aug 2010